These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

491 related items for PubMed ID: 11856090

  • 1. Low-dose lansoprazole and clarithromycin plus metronidazole vs. full-dose lansoprazole and clarithromycin plus amoxicillin for eradication of Helicobacter pylori infection.
    Bazzoli F, Zagari RM, Pozzato P, Fossi S, Ricciardiello L, Nicolini G, De Luca L, Berretti D, Alampi G, Di Pietro C, Morelli P, Roda E.
    Aliment Pharmacol Ther; 2002 Jan; 16(1):153-8. PubMed ID: 11856090
    [Abstract] [Full Text] [Related]

  • 2. A randomized trial of lansoprazole, amoxycillin, and clarithromycin versus lansoprazole, bismuth, metronidazole and tetracycline in the retreatment of patients failing initial Helicobacter pylori therapy.
    Magaret N, Burm M, Faigel D, Kelly C, Peterson W, Fennerty MB.
    Dig Dis; 2001 Jan; 19(2):174-8. PubMed ID: 11549829
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of low-dose clarithromycin triple therapy and tinidazole-containing triple therapy for Helicobacter pylori eradication.
    Choi IJ, Jung HC, Choi KW, Kim JH, Ahn DS, Yang US, Rew JS, Lee SI, Rhee JC, Chung IS, Chung JM, Hong WS.
    Aliment Pharmacol Ther; 2002 Jan; 16(1):145-51. PubMed ID: 11856089
    [Abstract] [Full Text] [Related]

  • 4. Incidence of duodenal ulcer healing after 1 week of proton pump inhibitor triple therapy for eradication of Helicobacter pylori. The Lansoprazole Helicobacter Study Group.
    Harris AW, Misiewicz JJ, Bardhan KD, Levi S, O'Morain C, Cooper BT, Kerr GD, Dixon MF, Langworthy H, Piper D.
    Aliment Pharmacol Ther; 1998 Aug; 12(8):741-5. PubMed ID: 9726387
    [Abstract] [Full Text] [Related]

  • 5. [Acquisition of secondary resistance after failure of a first treatment of Helicobacter pylori infection in children].
    Kalach N, Benhamou PH, Bergeret M, Gottrand F, Husson MO, Barbier C, Dupont C, Raymond J.
    Arch Pediatr; 2002 Feb; 9(2):130-5. PubMed ID: 11915493
    [Abstract] [Full Text] [Related]

  • 6. The selection of triple therapy for Helicobacter pylori eradication in chronic renal insufficiency.
    Sheu BS, Huang JJ, Yang HB, Huang AH, Wu JJ.
    Aliment Pharmacol Ther; 2003 May 15; 17(10):1283-90. PubMed ID: 12755841
    [Abstract] [Full Text] [Related]

  • 7. Double-blind, multicenter evaluation of lansoprazole and amoxicillin dual therapy for the cure of Helicobacter pylori infection.
    Harford W, Lanza F, Arora A, Graham D, Haber M, Weissfeld A, Rose P, Siepman N.
    Helicobacter; 1996 Dec 15; 1(4):243-50. PubMed ID: 9398875
    [Abstract] [Full Text] [Related]

  • 8. Prolonging proton pump inhibitor-based anti-Helicobacter pylori treatment from one to two weeks in duodenal ulcer: is it worthwhile?
    Maconi G, Russo A, Imbesi V, Cucino C, Bianchi Porro G.
    Dig Liver Dis; 2000 May 15; 32(4):275-80. PubMed ID: 11515622
    [Abstract] [Full Text] [Related]

  • 9. Comparison of two 3-day Helicobacter pylori eradication regimens with a standard 1-week regimen.
    Grimley CE, Penny A, O'sullivan M, Shebani M, Lismore JR, Cross R, Illing RC, Loft DE, Nwokolo CU.
    Aliment Pharmacol Ther; 1999 Jul 15; 13(7):869-73. PubMed ID: 10383520
    [Abstract] [Full Text] [Related]

  • 10. Lansoprazole and secnidazole with clarithromycin, amoxycillin or pefloxacin in the eradication of Helicobacter pylori in a developing country.
    Ahuja V, Dhar A, Bal C, Sharma MP.
    Aliment Pharmacol Ther; 1998 Jun 15; 12(6):551-5. PubMed ID: 9678815
    [Abstract] [Full Text] [Related]

  • 11. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
    Schwartz H, Krause R, Sahba B, Haber M, Weissfeld A, Rose P, Siepman N, Freston J.
    Am J Gastroenterol; 1998 Apr 15; 93(4):584-90. PubMed ID: 9576452
    [Abstract] [Full Text] [Related]

  • 12. Comparison of lansoprazole-based triple and dual therapy for treatment of Helicobacter pylori-related duodenal ulcer: an Asian multicentre double-blind randomized placebo controlled study.
    Wong BC, Xiao SD, Hu FL, Qian SC, Huang NX, Li YY, Hu PJ, Daldiyono, Manan C, Lesmana L, Carpio RE, Perez JY, Fock KM, Kachintorn U, Phornphutkul K, Kullavanijaya P, Ho J, Lam SK.
    Aliment Pharmacol Ther; 2000 Feb 15; 14(2):217-24. PubMed ID: 10651663
    [Abstract] [Full Text] [Related]

  • 13. Eradication of Helicobacter pylori by 7-day triple-therapy regimens combining pantoprazole with clarithromycin, metronidazole, or amoxicillin in patients with peptic ulcer disease: results of two double-blind, randomized studies.
    Bochenek WJ, Peters S, Fraga PD, Wang W, Mack ME, Osato MS, El-Zimaity HM, Davis KD, Graham DY, Helicobacter pylori Pantoprazole Eradication (HELPPE) Study Group.
    Helicobacter; 2003 Dec 15; 8(6):626-42. PubMed ID: 14632678
    [Abstract] [Full Text] [Related]

  • 14. Duodenal ulcer healing after 7-day treatment: a pilot study with lansoprazole, amoxicillin and clarithromycin.
    Schütze K, Hentschel E.
    Z Gastroenterol; 1995 Nov 15; 33(11):651-3. PubMed ID: 8600661
    [Abstract] [Full Text] [Related]

  • 15. Lafutidine, a novel histamine H2-receptor antagonist, vs lansoprazole in combination with amoxicillin and clarithromycin for eradication of Helicobacter pylori.
    Isomoto H, Inoue K, Furusu H, Nishiyama H, Shikuwa S, Omagari K, Mizuta Y, Murase K, Murata I, Kohno S.
    Helicobacter; 2003 Apr 15; 8(2):111-9. PubMed ID: 12662378
    [Abstract] [Full Text] [Related]

  • 16. Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial.
    Chey WD, Fisher L, Elta GH, Barnett JL, Nostrant T, DelValle J, Hasler WL, Scheiman JM.
    Am J Gastroenterol; 1997 Sep 15; 92(9):1483-6. PubMed ID: 9317068
    [Abstract] [Full Text] [Related]

  • 17. Double vs. single dose of pantoprazole in combination with clarithromycin and amoxycillin for 7 days, in eradication of Helicobacter pylori in patients with non-ulcer dyspepsia.
    Lamouliatte H, Samoyeau R, De Mascarel A, Megraud F.
    Aliment Pharmacol Ther; 1999 Nov 15; 13(11):1523-30. PubMed ID: 10571611
    [Abstract] [Full Text] [Related]

  • 18. One-week therapy with omeprazole, clarithromycin and metronidazole or ornidazole, followed by 3 weeks' treatment with omeprazole, eradicates Helicobacter pylori equally and heals duodenal ulcer.
    Tzivras M, Archimandritis A, Balatsos V, Delis V, Souyioultzis S, Skandalis N, Kanellopoulou E, Manika Z, Davaris P.
    Eur J Gastroenterol Hepatol; 1997 Dec 15; 9(12):1185-9. PubMed ID: 9471024
    [Abstract] [Full Text] [Related]

  • 19. A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
    Asaka M, Sugiyama T, Kato M, Satoh K, Kuwayama H, Fukuda Y, Fujioka T, Takemoto T, Kimura K, Shimoyama T, Shimizu K, Kobayashi S.
    Helicobacter; 2001 Sep 15; 6(3):254-61. PubMed ID: 11683930
    [Abstract] [Full Text] [Related]

  • 20. A randomized comparison of four omeprazole-based triple therapy regimens for the eradication of Helicobacter pylori in patients with non-ulcer dyspepsia.
    Laurent J, Mégraud F, Fléjou JF, Caekaert A, Barthélemy P.
    Aliment Pharmacol Ther; 2001 Nov 15; 15(11):1787-93. PubMed ID: 11683693
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.